Published Papers & Misc - ASHIDA Hiroshi

Division display  21 - 40 of about 40 ／  All the affair displays >>

  1. Hiroshi Ashida, Minsoo Kim, Chihiro Sasakawa. Exploitation of the host ubiquitin system by human bacterial pathogens. Nat. Rev. Microbiol.. 2014.06; 12 (6): 399-413. ( PubMed, DOI )

  2. Taira Kobayashi, Michinaga Ogawa, Takahito Sanada, Hitomi Mimuro, Minsoo Kim, Hiroshi Ashida, Reiko Akakura, Mitsutaka Yoshida, Magdalena Kawalec, Jean-Marc Reichhart, Tsunehiro Mizushima, Chihiro Sasakawa. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe. 2013.05; 13 (5): 570-583. ( PubMed, DOI )

  3. Hiroshi Ashida, Hiroyasu Nakano, Chihiro Sasakawa. Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells. PLoS Pathog.. 2013; 9 (6): e1003409. ( PubMed, DOI )

  4. Takahito Sanada, Minsoo Kim, Hitomi Mimuro, Hiroshi Ashida, Michinaga Ogawa, Tsunehiro Mizushima, Chihiro Sasakawa. A bacterial effector targets the TRAF6-NFκB pathway to modulate the acute inflammatory response to bacterial invasion of epithelial cells. Virulence. 2012.10; 3 (6): 518-521. ( PubMed, DOI )

  5. Takahito Sanada, Minsoo Kim, Hitomi Mimuro, Masato Suzuki, Michinaga Ogawa, Akiho Oyama, Hiroshi Ashida, Taira Kobayashi, Tomohiro Koyama, Shinya Nagai, Yuri Shibata, Jin Gohda, Jun-ichiro Inoue, Tsunehiro Mizushima, Chihiro Sasakawa. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature. 2012.03; 483 (7391): 623-626. ( PubMed, DOI )

  6. Hiroshi Ashida, Michinaga Ogawa, Minsoo Kim, Hitomi Mimuro, Chihiro Sasakawa. Bacteria and host interactions in the gut epithelial barrier. Nat. Chem. Biol.. 2011.12; 8 (1): 36-45. ( PubMed, DOI )

  7. Hiroshi Ashida, Hitomi Mimuro, Michinaga Ogawa, Taira Kobayashi, Takahito Sanada, Minsoo Kim, Chihiro Sasakawa. Cell death and infection: a double-edged sword for host and pathogen survival. J. Cell Biol.. 2011.12; 195 (6): 931-942. ( PubMed, DOI )

  8. Hiroshi Ashida, Michinaga Ogawa, Hitomi Mimuro, Taira Kobayashi, Takahito Sanada, Chihiro Sasakawa. Shigella are versatile mucosal pathogens that circumvent the host innate immune system. Curr. Opin. Immunol.. 2011.08; 23 (4): 448-455. ( PubMed, DOI )

  9. Michinaga Ogawa, Hitomi Mimuro, Yuko Yoshikawa, Hiroshi Ashida, Chihiro Sasakawa. Manipulation of autophagy by bacteria for their own benefit. Microbiol. Immunol.. 2011.07; 55 (7): 459-471. ( PubMed, DOI )

  10. Nozomi Ishijima, Masato Suzuki, Hiroshi Ashida, Yusuke Ichikawa, Yumi Kanegae, Izumu Saito, Thomas Borén, Rainer Haas, Chihiro Sasakawa, Hitomi Mimuro. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J. Biol. Chem.. 2011.07; 286 (28): 25256-25264. ( PubMed, DOI )

  11. Michinaga Ogawa, Yuko Yoshikawa, Taira Kobayashi, Hitomi Mimuro, Makoto Fukumatsu, Kotaro Kiga, Zhenzi Piao, Hiroshi Ashida, Mitsutaka Yoshida, Shigeru Kakuta, Tomohiro Koyama, Yoshiyuki Goto, Takahiro Nagatake, Shinya Nagai, Hiroshi Kiyono, Magdalena Kawalec, Jean-Marc Reichhart, Chihiro Sasakawa. A Tecpr1-dependent selective autophagy pathway targets bacterial pathogens. Cell Host Microbe. 2011.05; 9 (5): 376-389. ( PubMed, DOI )

  12. Hiroshi Ashida, Michinaga Ogawa, Minsoo Kim, Shiho Suzuki, Takahito Sanada, Claire Punginelli, Hitomi Mimuro, Chihiro Sasakawa. Shigella deploy multiple countermeasures against host innate immune responses. Curr. Opin. Microbiol.. 2011.02; 14 (1): 16-23. ( PubMed, DOI )

  13. Minsoo Kim, Hiroshi Ashida, Michinaga Ogawa, Yuko Yoshikawa, Hitomi Mimuro, Chihiro Sasakawa. Bacterial interactions with the host epithelium. Cell Host Microbe. 2010.07; 8 (1): 20-35. ( PubMed, DOI )

  14. Hiroshi Ashida, Minsoo Kim, Marc Schmidt-Supprian, Averil Ma, Michinaga Ogawa, Chihiro Sasakawa. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol.. 2010.01; 12 (1): 66-73; sup pp 1. ( PubMed, DOI )

  15. Hiroshi Ashida, Michinaga Ogawa, Hitomi Mimuro, Chihiro Sasakawa. Shigella infection of intestinal epithelium and circumvention of the host innate defense system. Curr. Top. Microbiol. Immunol.. 2009; 337 231-255. ( PubMed, DOI )

  16. Michinaga Ogawa, Yutaka Handa, Hiroshi Ashida, Masato Suzuki, Chihiro Sasakawa. The versatility of Shigella effectors. Nat. Rev. Microbiol.. 2008.01; 6 (1): 11-16. ( PubMed, DOI )

  17. Hiroki Iwai, Minsoo Kim, Yuko Yoshikawa, Hiroshi Ashida, Michinaga Ogawa, Yukihiro Fujita, Daniel Muller, Teruo Kirikae, Peter K Jackson, Shuji Kotani, Chihiro Sasakawa. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell. 2007.08; 130 (4): 611-623. ( PubMed, DOI )

  18. Toshihiko Suzuki, Luigi Franchi, Claudia Toma, Hiroshi Ashida, Michinaga Ogawa, Yuko Yoshikawa, Hitomi Mimuro, Naohiro Inohara, Chihiro Sasakawa, Gabriel Nuñez. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog.. 2007.08; 3 (8): e111. ( PubMed, DOI )

  19. Hiroshi Ashida, Takahito Toyotome, Takeshi Nagai, Chihiro Sasakawa. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol. Microbiol.. 2007.02; 63 (3): 680-693. ( PubMed, DOI )

  20. Toshihiko Suzuki, Yuko Yoshikawa, Hiroshi Ashida, Hiroki Iwai, Takahito Toyotome, Hidenori Matsui, Chihiro Sasakawa. High vaccine efficacy against shigellosis of recombinant noninvasive Shigella mutant that expresses Yersinia invasin. J. Immunol.. 2006.10; 177 (7): 4709-4717. ( PubMed, DOI )

< PREV - NEXT >

  • 1
  • 2
To the head of this page.▲